References
Vingerhoets FJG, Schulzer M, Calne DB, Snow BJ (1997) Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann Neurol 41: 58–64
Benamer HTS, Patterson J, Wyper DJ, et al (2000) Correlation of Parkinson's disease severity and duration with I-123-FP-CIT SPECT striatal uptake. Mov Disord 15: 692–698
Lamarre Y (1984) Animal models of tremor. In: Findley LJ, Capildeo R (eds) Movement disorders: tremor. Mac-Millan Press, London pp 183–194
Doder M, Rabiner EA, Turjanski N, et al (2003) Tremor in Parkinson's disease and serotonergic dysfunction: an (11)C-WAY 100635 PET study. Neurology 60: 601–605
Cheesman AL, Barker RA, Lewis SJ, et al (2005) Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease. J Neurol Neurosurg Psychiatry 76: 1204–1210
Remy P, Doder M, Lees AJ, Turjanski N, Brooks DJ (2005) Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128: 1314–1322
Playford ED, Jenkins IH, Passingham RE, et al (1992) Impaired mesial frontal and putamen activation in Parkinson's disease: a PET study. Ann Neurol 32: 151–161
Haslinger B, Erhard P, Kampfe N, et al (2001) Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124: 558–570
Brefel-Courbon C, Payoux P, Thalamas C, et al (2005) Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 20: 1557–1563
Jenkins IH, Fernandez W, Playford ED, et al (1992) Impaired activation of the supplementary motor area in Parkinson' s disease is reversed when akinesia is treated with apomorphine. Ann Neurol 32: 749–757
Rascol O, Sabatini U, Chollet F, et al (1992) Supplementary and primary sensory motor area activity in Parkinson' s disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 49: 144–148
Rascol O, Sabatini U, Chollet F, et al (1994) Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J Neurol Neurosurg Psychiatry 57: 567–571
Koepp MJ, Gunn RN, Lawrence AD, et al (1998) Evidence for striatal dopamine release during a video game. Nature 393: 266–268
Lawrence AD, Brooks DJ (1999) Neural correlates of reward processing in the human brain: A PET study. Neurology 52 [Suppl 2]: A307
Goerendt IK, Messa C, Lawrence AD, et al (2003) Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study. Brain 126: 312–325
Piccini P, Pavese N, Brooks DJ (2003) Endogenous dopamine release after pharmacological challenges in Parkinson's disease. Ann Neurol 53: 647–653
Piccini P, Pavese N, Brooks DJ (2002) Effects of methamphetamine on mood correlate with endogenous dopamine release in frontal areas. Neurology 58 [Suppl 3]: A357
Evans AH, Pavese N, Lawrence AD, et al (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59: 852–858
Evans AH, Lees AJ (2004) Dopamine dysregulation syndrome in Parkinson's disease. Curr Opin Neurol 17: 393–398
Rights and permissions
About this article
Cite this article
Brooks, D. Imaging the role of dopamine in health and disease Parkinson's disease as a lesion model. Wien Klin Wochenschr 118, 570–572 (2006). https://doi.org/10.1007/s00508-006-0737-4
Issue Date:
DOI: https://doi.org/10.1007/s00508-006-0737-4